Publication | Open Access

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial

Antifibrotic TherapyAdvanced Lung DiseaseIdiopathic Pulmonary FibrosisPulmonary PharmacologyPulmonary FibrosisPulmonary MedicinePharmacotherapyMedicinePulmonary Disease